The investment landscape for marijuana companies has transitioned from a niche market to mainstream interest over the last decade as more Americans gain legal access to cannabis. By January 2026, recreational use is expected to be legal in 24 states, including Washington, D.C. and Guam, while 42 states will permit medical use. The U.S. cannabis market is projected to reach approximately $47 billion by 2026, drawing significant capital; however, investing in the marijuana sector remains complex and carries inherent risks.
This guide offers a comprehensive overview of what investors need to consider before purchasing marijuana stocks, detailing the industry structure, investment methods, and practical steps for entry.
The cannabis industry is broadly categorized into U.S. Multi-State Operators (MSOs) and Canadian Licensed Producers (LPs). MSOs generate the highest revenue but often trade on Over-The-Counter (OTC) markets, while many Canadian LPs list on major U.S. exchanges such as NASDAQ and NYSE without direct access to the U.S. retail market.
- Executive Order 14370, enacted in late 2025, rescheduled cannabis to Schedule III, potentially enhancing profitability by alleviating the burdensome 280E tax treatment. However, issues related to banking, custody, and trading continue to complicate investments.
- Investors can choose between individual stocks, which offer higher risk and reward, or exchange-traded funds (ETFs) that provide broader exposure with lower single-stock risk.
- U.S. MSOs listed on OTC markets may be challenging to access through some brokerage platforms, exhibiting wider bid-ask spreads and lower liquidity compared to their Canadian counterparts and ETFs.
Publicly traded cannabis companies are relatively scarce and often newer than those in other sectors. Following Canada’s legalization of recreational cannabis in October 2018, many of the more significant public firms are Canadian. The cannabis industry consists of three primary categories:
Growers and Operators
- U.S. MSOs: These vertically integrated businesses cultivate, process, and retail across multiple states. Companies such as Green Thumb and Trulieve are leading players in terms of revenue but typically trade on OTC markets due to federal regulations.
- Canadian LPs: Headquartered in Canada, these licensed producers, including Tilray and Canopy Growth, primarily trade on major U.S. exchanges but lack direct access to the U.S. retail cannabis market.
Industry Players
These are companies that offer specialized services or assets within the cannabis ecosystem, such as pharmaceutical firms, packaging companies, or real estate investment trusts like Innovative Industrial Properties (IIPR).
Ancillary Companies
These businesses operate outside the core cannabis sector, providing products or services that support growers and dispensaries, including technology, hydroponics, and compliance software.
Risk Profile: Companies closer to cultivation and retail are generally more volatile. Major cannabis stocks have exhibited volatility rates that are frequently more than double those of the S&P 500, and many public cannabis firms have small market capitalizations, intensifying price fluctuations.
Understanding the Risks Associated with Marijuana Stocks:
- Speculative Nature: Many public cannabis firms are still in the process of scaling operations and establishing positive cash flow.
- Regulatory Challenges: Variations in state regulations, along with changes in legalization or licensing, can significantly impact revenue streams.
- Federal Limitations: Federal restrictions hinder access to normal banking and trading functions. While the recent rescheduling may enhance profitability for U.S. operators, challenges remain in implementation.
- Liquidity Issues: MSOs trading on OTC can present hurdles, including wider bid-ask spreads and limited liquidity. Retail trading platforms often restrict access to these stocks.
- Possible Share Dilution: Smaller companies may frequently issue equity to fund operations, leading to dilution for existing shareholders.
Investment Opportunities in Marijuana Stocks:
Investors primarily have two options: purchasing shares of cannabis-related companies or investing in funds that track the industry.
Individual Stocks
Acquiring shares of individual cannabis companies can yield substantial rewards or significant losses. It is essential to conduct thorough research comparable to that for any stock: reviewing financial statements, analyzing balance sheets, understanding business models, and assessing competitive standings.
Key Metrics to Monitor:
- Revenue growth and profit margins
- Cash flow stability and funding access
- Geographic distribution and revenue generation per outlet for MSOs
- Exposure to regulatory changes and licensing stability
- Management proficiency, ownership stake, and track record
- Debt levels and financial structure
- Market listing (OTC vs NASDAQ/NYSE) and trade volume
Top Market Players for 2026:
- Curaleaf Holdings (CURLF) — U.S. MSO
- Green Thumb Industries (GTBIF) — U.S. MSO
- Trulieve Cannabis (TCNNF) — U.S. MSO
- Verano Holdings (VRNOF) — U.S. MSO
- Tilray Brands (TLRY) — Canadian LP (NASDAQ)
- Innovative Industrial Properties (IIPR) — REIT (NYSE)
- Cronos Group (CRON) — Canadian LP (NASDAQ)
- Cresco Labs (CRLBF) — U.S. MSO
- Glass House Brands (GLASF) — U.S. Cultivator
- Canopy Growth (CGC) — Canadian LP (NASDAQ)
Investors should recognize that this landscape is subject to rapid changes, making these names starting points rather than definitive investment recommendations.
Marijuana ETFs
Exchange-traded funds (ETFs) provide a simpler method for investors to gain diversified exposure to the cannabis sector while mitigating the risks associated with individual stocks. After several closures within the ETF market in 2023-2024, key surviving funds include:
- AdvisorShares Pure U.S. Cannabis ETF (MSOS): The largest ETF focused solely on U.S. operators.
- Amplify Alternative Harvest ETF (MJ): Offers global exposure, primarily weighted towards Canadian LPs and partnerships with tobacco and pharmaceutical companies.
- AdvisorShares Pure Cannabis ETF (YOLO): An actively managed fund featuring a blend of U.S. and global stocks.
- Amplify Seymour Cannabis ETF (CNBS): Also actively managed.
- Roundhill Cannabis ETF (WEED): A tier-weighted index of U.S. MSOs.
- Cambria Cannabis ETF (TOKE): Concentrates on value and quality across the cannabis ecosystem.
Integrating Marijuana Stocks into Your Portfolio:
Investing in cannabis stocks carries more risk compared to many traditional sectors. Should you choose to invest:
- Consider allocating a small percentage of your overall portfolio for speculative investments, with specific guidelines varying based on personal risk tolerance.
- Opt for ETFs if you prefer not to select individual winners or experience stock volatility.
- Be aware that some index funds and small-cap ETFs may already encompass cannabis firms, so it’s prudent to review your existing portfolio before adding exposure.
Steps for Purchasing Marijuana Stocks:
- Determine your desired exposure. Individual stocks for potentially high returns, ETFs for broader diversification, or a mix of both.
- Choose a brokerage that allows for trading in the selected markets. U.S. MSOs often trade OTC, necessitating brokers that support OTC transactions, while most retail apps may restrict these stocks.
- Conduct thorough research. Evaluate earnings reports, investor communications, and analyst insights; assess financial health, regulatory risks, and competitive positions.
- Consider market structure and order types. For OTC stocks and low liquidity companies, limit orders are preferable to avoid unfavorable spreads.
- Diversify and manage position sizes. Avoid concentrating too much of your portfolio in one cannabis stock; consider spreading investments across various MSOs, LPs, and ancillary businesses, or utilize an ETF.
- Stay informed about regulatory changes. Monitor developments relevant to federal regulations, state legalizations, and tax adjustments that may affect stock valuations.
- Be aware of tax and custody issues. Trading in OTC and small-cap stocks can entail unique tax considerations; seeking advice from a tax professional is recommended.
For additional insights and resources, readers may explore related articles, including best practices in gold investment, stock market forecasts for 2026, and guidance on purchasing cryptocurrency anonymously.